The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study

The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Raffaele Scarpa &Mariangela Atteno & Ennio Lubrano & Giuseppe Provenzano & Salvatore D’Angelo & Antonio Spadaro & Luisa Costa & Ignazio Olivieri
  • چاپ و سال / کشور: 2011

Description

The objective of this study is to assess the effectiveness and safety of TNF-ƒ؟ blockers in a group of early psoriatic arthritis (PsA) patients with an unsatisfactory response to previous conventional treatment consecutively enrolled in five Italian centres. A 24-week open-label trial was carried out in consecutive early PsA patients classified according to the CASPAR criteria, with unsatisfactory response to previous treatments and with a DAS28 threshold as .3.2, seen at the outpatient clinics of each centre. Exclusion criteria were previous usage of TNF-ƒ؟ blockers and a disease duration >12 months. The choice of any of the three TNF-ƒ؟ blockers was decided by the expertپfs opinion, without any restriction. Effectiveness was considered as an improvement of DAS28 at 12 and 24 weeks of treatment. Secondary endpoints were an improvement of TJC, SWJ, HAQ score and PASI score. Changes from baseline to the 12- and 24-week follow-up assessments were analysed using the Wilcoxon paired sign rank test. Twenty-nine patients (14 males, 15 females, median age 37 years, range 20.65 years) were enrolled. A statistical improvement of the DAS28 was observed at 12 and 24 weeks from baseline (p<0.001). Secondary endpoints also confirmed the effectiveness of the TNF-ƒ؟ blockers in the treatment of early PsA. No severe adverse events were observed during the treatment period, and no patient withdrew from the medications. This study suggests that the TNF-ƒ؟ blockers can be effective in the management of early PsA. Further controlled studies will provide more data on this challenging topic.
Clin Rheumatol (2011) 30:1063–1067 Received: 20 September 2010 / Revised: 27 December 2010 / Accepted: 3 January 2011 / Published online: 1 March 2011
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری